Edgewise Therapeutics, Inc.
EWTX
$44.17
$0.992.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -22.44% | 14.48% | 12.75% | 14.38% | 16.07% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -30.42% | 50.64% | 149.88% | 53.04% | 20.46% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.84% | 15.03% | 14.28% | 14.91% | 16.14% |
|
|
|||||
| Total Current Assets | -21.84% | 15.03% | 14.28% | 14.91% | 16.14% |
| Net Property, Plant & Equipment | -18.94% | -17.00% | -16.74% | -17.42% | -15.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -21.79% | 14.11% | 13.51% | 14.12% | 15.36% |
|
|
|||||
| Total Accounts Payable | -43.92% | -17.02% | 7.65% | 8.99% | 22.33% |
| Total Accrued Expenses | 18.95% | 25.68% | 17.73% | 17.58% | 23.28% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.69% | 1.60% | 1.81% | 1.61% | 1.62% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 38.98% | 6.76% | 14.71% | 14.18% | 21.66% |
|
|
|||||
| Total Current Liabilities | 38.98% | 6.76% | 14.71% | 14.18% | 21.66% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -23.70% | -21.96% | -20.45% | -7.98% | -15.76% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.28% | 2.62% | 9.95% | 10.77% | 14.59% |
|
|
|||||
| Common Stock & APIC | 5.45% | 28.30% | 27.54% | 27.50% | 27.94% |
| Retained Earnings | -43.30% | -41.97% | -44.32% | -46.40% | -49.45% |
| Treasury Stock & Other | -345.10% | -162.84% | 61.19% | -33.30% | 119.35% |
| Total Common Equity | -23.93% | 14.77% | 13.73% | 14.27% | 15.40% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.93% | 14.77% | 13.73% | 14.27% | 15.40% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.93% | 14.77% | 13.73% | 14.27% | 15.40% |
|
|
|||||